Global Erectile Dysfunction Market 2016-2020

Overview of the erectile dysfunction market

According to the erectile dysfunction market analysis, the global erectile dysfunction market is anticipated to witness slow growth and will reach close to USD 4 billion by the end of 2020. Globally, there has been an increase in the number of people with prostate cancer, which is one of the most common types of cancers among men. The treatment involves the removal of the prostate gland, which can result in impaired sexual function in at least half of the men who undergo this treatment. Prostate cancer does not directly cause erectile dysfunction (ED). However, the treatment methods, such as surgery with radical prostatectomy, hormone therapy or radiation therapy can cause ED among men.

One of the emerging trends propelling this market’s growth prospects is the augmented demand for penile implants. In many countries, the demand for penile implants is increasing as a result of the growing number of ED cases. This has led many pharmaceutical firms to invest in the R&D of new technologies to develop new products and upgrade their existing offerings. Furthermore, many countries in APAC such as China and Japan have a large older adult population. Penile implants were first introduced in China in 2002 but witnessed limited adoption due to its high cost and poor acceptance. However, by reviving the global economy and an increase in disposable income, the market for penile implants is likely to show a gradual growth during the forecast period and will increase the erectile dysfunction market size.

Competitive landscape and key vendors